Swedish Real-World MS Data Demonstrates Long-Term Safety and Effectiveness of Cladribine

At ECTRIMS 2025, Linda Forsberg, Project Coordinator at the Department of Clinical Neuroscience, Karolinska Institutet, presented Swedish real-world data demonstrating the long-term safety and effectiveness of cladribine tablets in MS patients. The IMSE study showed stable or improved clinical outcomes, significant relapse reduction, and low treatment discontinuation over 36 months.